Biliary excretion of etoposide in children with cancer

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 3, 2006, Pages 415-417

  Veal, Gareth J ^a   Errington, Julie ^a   Thomas, Huw D ^a   Boddy, Alan V ^a   Lowis, Stephen ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Bile; Etoposide; Paediatric; Pharmacokinetics

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; BILE DUCT OBSTRUCTION; BILE FLOW; BILIARY EXCRETION; BILIARY TRACT DRAINAGE; CASE REPORT; CHILDHOOD CANCER; CONTINUOUS INFUSION; DOSE TIME EFFECT RELATION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; FEMALE; HUMAN; HYPOPROTEINEMIA; LIQUID CHROMATOGRAPHY; LIVER DYSFUNCTION; MALE; MASS SPECTROMETRY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SIDE EFFECT; SOFT TISSUE SARCOMA;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BILE; CHILD, PRESCHOOL; DRAINAGE; ETOPOSIDE; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; SARCOMA;

EID: 33744485560     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0180-7     Document Type: Article

References (9)

1. Bennett CL, Sinkule JA, Schilsky RL, Senekjian E, Choi KE (1987) Phase 1 clinical and pharmacological study of seventy two hour infusion of etoposide in patients with advanced cancer. Cancer Res 47:1952
2. D'Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Pisoni MB, Piaza E, Beer M, Cavalli F (1982) Pharmacokinetics of VP16-213 given by different administration methods. Cancer Chemother Pharmacol 7:141
3. Evans WE, Sinkule JA, Crom W, Dow L, Look AT, Rivera G (1982) Pharmacokinetics of teniposide (VM26) and etoposide (VP16) in children with cancer. Cancer Chemother Pharmacol 7:147
4. Hande KR, Wolff SN, Greco FA, Hainsworth JD, Reed G, Johnson DH (1990) Etoposide kinetics in patients with obstructive jaundice. J Clin Oncol 8:1101
5. Joel SP, Shah R, Clark PI, Slevin ML (1996) Predicting etoposide toxicity: relationship to organ function and protein binding. J Clin Oncol 14:257
6. Liu B, Earl HM, Poole CJ, Dunn J, Kerr DJ (1995) Etoposide protein-binding in cancer patients. Cancer Chemother Pharmacol 36:506
7. Lowis SP, Pearson AD, Newell DR, Boddy AV (1993) Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. Cancer Res 53:4881
8. Sinkule JA, Hutson P, Hayes FA, Etcubanas E, Evans WE (1984) Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumours. Cancer Res 44:3109
9. Stewart CF, Arbuck SG, Fleming RA, Evans WE (1990) Changes in the clearance of total and unbound etoposide in patients with liver dysfunction. J Clin Oncol 8:1874